COMPARATIVE EFFICACY AND SAFETY OF NEW ORAL ANTICOAGULANTS

COMPARATIVE EFFICACY AND SAFETY OF NEW ORAL ANTICOAGULANTS

Show other versions (1)

Indirect comparisons of new oral anticoagulants are performed with focus on their safety. Apixaban, an oral inhibitor of Xa factor, nowadays can be considered as a drug with very good safety profile according to randomized trials results and performed indirect comparisons.

Bibliographic Details
Main Authors: V. A. Sulimov, D. A. Napalkov, A. A. Sokolova
Format: Article
Language:English
Published: Stolichnaya Izdatelskaya Kompaniya 2015-09-01
Series:Racionalʹnaâ Farmakoterapiâ v Kardiologii
Subjects:
фибрилляция предсердий
профилактика инсульта
геморрагические осложнения
апиксабан
дабигатран
ривароксабан
Online Access:http://www.rpcardio.ru/jour/article/view/109
Description
Summary:Indirect comparisons of new oral anticoagulants are performed with focus on their safety. Apixaban, an oral inhibitor of Xa factor, nowadays can be considered as a drug with very good safety profile according to randomized trials results and performed indirect comparisons.
ISSN:1819-6446
2225-3653

Similar Items